Drug recall · June 2, 2021
EPINEPHRINE INJECTION USP recall
Why: CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
EPINEPHRINE INJECTION USP, 0.15 MG (AUTO-INJECTORS) FOR ALLERGIC EMERGENCIES (ANAPHYLAXIS) 2 Auto-Injectors and 1 Trainer, Manufactured for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-5985-27
- Lots / codes
025C20AA
- Quantity
- 1776 boxes
- Company
- Cardinal Health Inc., Dublin, OH
- Distribution
- FL, GA, SC
- Initiated
- March 15, 2021 · Voluntary: Firm initiated
- Classified
- May 24, 2021
- Reported
- June 2, 2021
- Ended
- June 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Epinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.